RECOVERY trial finds plasma doesn't improve survival in hospitalised Covid patients: Lancet
The study cautions against the use of plasma therapy due to insufficient evidence on its efficacy.
Stay updated with breaking news from Plasmar Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study cautions against the use of plasma therapy due to insufficient evidence on its efficacy.
Covid-19 Task Force to Meet Tomorrow for Plasma Therapy Review, New Guidelines Likely Runjhun Sharma © Provided by News18 Covid-19 Task Force to Meet Tomorrow for Plasma Therapy Review, New Guidelines Likely India’s national task force on Covid-19 management will meet on Friday (May 14) to review the convalescent plasma therapy for patients infected by the Sars-Cov-2 virus, sources have told CNN-News18, a development that comes in the backdrop of concerns over the use of the treatment and doubts over its efficacy. Revised guidelines and protocols on the use of the therap...
NAGPUR: The Nagpur bench of Bombay high court, in an observation, quoted scientists to state that convalescent plasma therapy is possibly leading to new Covid-19 viral strains and thus fuelling the pandemic. Quoting researchers from the University of Basel in Switzerland, a division bench added that the scientists’ observations have led to concern over use of this therapy, although no scientific or conclusive research was conducted on this finding. The bench directed citybased National Environmental Engineering Research Institute (Neeri) to conduct research on use of plasma therapy and it...
"We will deliberate on plasma therapy," Balram Bhargava, director general, ICMR told The Economic Times.
COVID: Public Health Experts Pen Concerns About Plasma to PSA VijayRaghavan 11/05/2021 A pouch of convalescent plasma from a person who recovered from COVID-19. Photo: Lindsey Wasson/Reuters When the number of COVID-19 cases began to surge in many parts of India from late April, the Centre’s and various state government’s failure to anticipate the second wave, and the inability of the Indian people at large to withstand it without additional protections, became glaringly obvious. A shortage of oxygen and antiviral and palliative drugs soon followed. With government help out of ...